Related Articles
An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins
Effective introduction of T cell costimulatory molecules into virus modified tumor cell vaccines by modification with bispecific antibodies
Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: Results from a phase Ⅰ clinical study
Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes
Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity